COGT (Cogent Biosciences) Short Interest


COGT Cogent Biosciences Inc COGT
25 GF Score
Price $37.81
! 3 Warning Signs
View Full Analysis

What is Cogent Biosciences Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

COGT vs SRRK, RYTM, PTCT: Short Interest Comparison

For the Biotechnology subindustry, Cogent Biosciences's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cogent Biosciences Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cogent Biosciences's Short Interest distribution charts can be found below:

* The bar in red indicates where Cogent Biosciences's Short Interest falls into.


COGT
25GF Score
Cogent Biosciences Inc COGT
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cogent Biosciences Business Description

Address 275 Wyman Street, 3rd Floor, Waltham, MA, USA, 02451
Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.
25GF Score

Get the complete analysis for COGT

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$37.81
Price